Paperpal Prime Logo

Journal of Infection and Chemotherapy : Impact Factor & More

eISSN: 1437-7780pISSN: 1341-321X

Key Metrics

CiteScore
3.5
Impact Factor
< 5
Scite Index
0.83 5-Year SI
SJR
Q3Infectious Diseases
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Infection and Chemotherapy

Journal of Infection and Chemotherapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Infection and Chemotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Infection and Chemotherapy

Bovine lactoferrin confers antiviral effect against La Crosse Virus by interfering with virus-heparan sulfate proteoglycan binding.
  • 6 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Macrolide resistance rate and antimicrobial selection in pediatric Mycoplasma pneumoniae infection during 2024.
  • 6 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohort.
  • 4 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Quantitative evaluation of pyuria with a hemocytometer in children on clean intermittent catheterization.
  • 1 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Impact of the "DPC Special Provision" on COVID-19 inpatient case identification in Japanese administrative databases.
  • 1 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Matching-adjusted comparison of the effectiveness and safety of Ensitrelvir versus Remdesivir for high-risk, hospitalized patients with non-severe COVID-19 in Japan.
  • 1 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Bovine lactoferrin confers antiviral effect against La Crosse Virus by interfering with virus-heparan sulfate proteoglycan binding.
  • 6 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Macrolide resistance rate and antimicrobial selection in pediatric Mycoplasma pneumoniae infection during 2024.
  • 6 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Twenty-four month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world data from the BICSTaR Japan cohort.
  • 4 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Quantitative evaluation of pyuria with a hemocytometer in children on clean intermittent catheterization.
  • 1 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Impact of the "DPC Special Provision" on COVID-19 inpatient case identification in Japanese administrative databases.
  • 1 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Matching-adjusted comparison of the effectiveness and safety of Ensitrelvir versus Remdesivir for high-risk, hospitalized patients with non-severe COVID-19 in Japan.
  • 1 Aug 2026
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

FAQs on Journal of Infection and Chemotherapy